Filing Flows

Filing Flows › Companies › Sabra Health Care REIT › Cash flow

Sabra Health Care REIT cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$129M in Q3 2026 · $401M over twelve months

Operating cash flow$129M
Free cash flow+$129M
Cash / net income4.5×

Analysis

In Q3 2026, Sabra Health Care REIT generated $129M of operating cash flow. That is $29.0M more than in Q3 2025 ($100M).

Over the twelve months to Sep 30, 2026, operating cash flow was $401M; the largest uses were real estate bought ($668M), dividends ($303M), net borrowing (+) / repaid (−) ($155M); besides operations, cash came from other investing ($361M), other financing ($209M); the cash balance fell by $164M.

Operating cash flow was $129M against net income of $28.6M — 4.5× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$64.8M, payables +$19.8M, prepaid and other assets −$4.5M.

Free cash flow

Sabra Health Care REIT: free cash flow by quarterSabra Health Care REIT: free cash flow by quarter$80.0MQ4 2024$80.3MQ1 2025$81.0MQ2 2025$100MQ3 2025$87.4MQ4 2025$98.4MQ1 2026$85.8MQ2 2026$129MQ3 2026
Operating cash flow less capital spending.
Sabra Health Care REIT: operating cash flow against capital spendingSabra Health Care REIT: operating cash flow against capital spendingOperating cash flowCapital spending$80.0M$0Q4 2024$80.3M$0Q1 2025$81.0M$0Q2 2025$100M$0Q3 2025$87.4M$0Q4 2025$98.4M$0Q1 2026$85.8M$0Q2 2026$129M$0Q3 2026
Latest (Q3 2026): Operating cash flow $129M, Capital spending $0.

Capital allocation, year by year

Sabra Health Care REIT: where the cash came from (up) and went (down), by fiscal yearSabra Health Care REIT: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingAsset salesDividendsFY2021: Operating cash flow $356MFY2021: Net borrowing $492MFY2021: Asset sales $101MFY2021: Dividends −$263M$949MFY2021FY2022: Operating cash flow $316MFY2022: Net borrowing $408MFY2022: Dividends −$277M$724MFY2022FY2023: Operating cash flow $301MFY2023: Net borrowing −$104MFY2023: Dividends −$277M$301MFY2023FY2024: Operating cash flow $311MFY2024: Net borrowing $14.6MFY2024: Dividends −$280M$325MFY2024FY2025: Operating cash flow $349MFY2025: Net borrowing −$390MFY2025: Dividends −$289M$349MFY2025
Over these 5 years operating cash flow totalled $1.6B; the largest uses were dividends ($1.4B) and net borrowing ($495M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$36.2M
Debt$2.4B
Net debt$2.4B
Due within a year$2.1M

Sabra Health Care REIT funds itself: free cash flow was $401M over the last twelve months, and $36.2M of cash and investments stands against $2.4B of debt ($2.1M due within a year, 16.9× covered by cash).

Sabra Health Care REIT: debt maturities by year (FY2025)Sabra Health Care REIT: debt maturities by year (FY2025)$2.1MYear 1$320MYear 2$542MYear 3$352MYear 4$502MYear 5$833MAfter year 5
Principal due in each year as disclosed in the annual report, against $36.2M of cash and investments now.

Where the cash came from and went

Sabra Health Care REIT: sources (+) and uses (−) of cash, Q3 2026Sabra Health Care REIT: sources (+) and uses (−) of cash, Q3 2026Real estate bought−$224MCash drawn (+) / kept (−)$195MNet borrowing (+) / repaid (−)−$192MOperating cash flow$129MOther financing$116MDividends−$76.6MOther investing$52.0MExchange rates−$129KPartners−$43K
Sabra Health Care REIT: sources (+) and uses (−) of cash, TTM to Q3 2026Sabra Health Care REIT: sources (+) and uses (−) of cash, TTM to Q3 2026Real estate bought−$668MOperating cash flow$401MOther investing$361MDividends−$303MOther financing$209MCash drawn (+) / kept (−)$164MNet borrowing (+) / repaid (−)−$155MTaxes on employees’ shares−$9.0MExchange rates$375KPartners$8K

From profit to cash

Sabra Health Care REIT: net income to operating cash flow, Q3 2026Sabra Health Care REIT: net income to operating cash flow, Q3 2026Net income$28.6MDepreciation & amortization$64.8MStock-based pay$3.9MPayables$19.8MPrepaid and other assets−$4.5MOperating cash flow$129M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowDividendsNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q3 2026$129M−$76.6M−$192M$195M$129M
Q2 2026$85.8M−$75.7M−$37.5M−$115M$85.8M
Q1 2026$98.4M−$75.7M$137M−$45.3M$98.4M
Q4 2025$87.4M−$74.8M−$65.0M$129M$87.4M
Q3 2025$100M−$71.9M$239M−$106M$100M
Q2 2025$81.0M−$71.4M$78.5M−$72.8M$81.0M
Q1 2025$80.3M−$71.4M−$24.4M$37.4M$80.3M
Q4 2024$80.0M−$71.0M−$44.2M$2.6M$80.0M

Sabra Health Care REIT: income statement and cash flow

Sabra Health Care REIT, Q3 2026: revenue $250M (+31% year over year), operating margin 11.5%. The chart follows the revenue to costs, profit and cash.

Sabra Health Care REIT: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.